🔗 Share this article

Texas Attorney General Paxton is taking legal action against the makers of acetaminophen, asserting the corporations withheld potential risks that the pain reliever posed to children's brain development.

This legal action comes a month after Donald Trump publicized an unsubstantiated connection between consuming acetaminophen - alternatively called paracetamol - during pregnancy and autism in offspring.

Paxton is suing the pharmaceutical giant, which once produced the drug, the only pain reliever approved for expectant mothers, and Kenvue, which currently produces it.

In a statement, he stated they "betrayed America by gaining financially from discomfort and promoting medication regardless of the potential hazards."

The company states there is lacking scientific proof linking acetaminophen to autism.

"These companies deceived for years, knowingly endangering countless individuals to increase profits," Paxton, from the Republican party, declared.

The company stated officially that it was "seriously troubled by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the welfare of women and children in America."

On its online platform, the company also stated it had "continuously evaluated the relevant science and there is lacking reliable evidence that indicates a verified association between taking acetaminophen and autism."

Groups acting on behalf of physicians and healthcare providers share this view.

The leading OB-GYN organization has stated paracetamol - the key substance in acetaminophen - is a restricted selection for women during pregnancy to address pain and fever, which can pose significant medical dangers if ignored.

"In more than two decades of studies on the utilization of paracetamol in gestation, no reliable research has conclusively proven that the usage of paracetamol in any period of gestation leads to neurodevelopmental disorders in young ones," the group commented.

The court filing cites recent announcements from the former administration in arguing the medication is reportedly hazardous.

Recently, the former president raised alarms from health experts when he advised women during pregnancy to "resist strongly" not to use acetaminophen when sick.

The FDA then issued a notice that medical professionals should consider limiting the use of acetaminophen, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in minors has not been proven.

The Health Department head Robert F Kennedy Jr, who oversees the FDA, had vowed in spring to initiate "comprehensive study program" that would establish the cause of autism in a matter of months.

But authorities advised that finding a sole reason of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and surrounding conditions - would not be simple.

Autism is a category of lifelong neurodivergence and disability that influences how individuals perceive and interact with the surroundings, and is diagnosed using physician assessments.

In his legal document, the attorney general - aligned with the former president who is seeking federal office - claims the manufacturer and Johnson & Johnson "willfully ignored and sought to suppress the science" around acetaminophen and autism spectrum disorder.

The case attempts to require the corporations "eliminate any commercial messaging" that states Tylenol is reliable for women during pregnancy.

This legal action mirrors the complaints of a assembly of guardians of minors with autism spectrum disorder and ADHD who took legal action against the makers of Tylenol in recently.

The court threw out the lawsuit, declaring studies from the parents' expert witnesses was not conclusive.